ASAlhassan Abdullahi Sharif

Alhassan Abdullahi Sharif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alhassan Abdullahi Sharif has a total of 119 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Population-Level Biological Protection against Severe COVID-19 in West Africa: Findings from a 20,748-Participant Multi-Country Phased Seroepidemiology Study

    by Aniefiok Udoakang, Daniel Oduro-Mensah, Gloria Amegatcher, Onikepe Folarin, Isah Abubakar Aliyu, Irene Amoakoh Owusu, Francis Dzabeng, Alphonse Ouedraogo, Reuben Ayivor-Djanie, Jones Gyamfi, et al.

    Background: Africa seemed to have had low SARS-CoV-2 infection and COVID-19 morbidity and mortality. While several studies reported high SARS-CoV-2 seropositivity among healthy Africans, others hypothesized that this could have resulted from pre-existing cross-reactive antibodies. Our study tracks trends in seropositivity across three West African countries during the Delta and Omicron pandemic waves using a validated test kit with 98.9% predictive accuracy, 97% sensitivity, and 99% specificity.Methods: Cross-sectional studies were conducted across three West African countries (Burkina Faso, Ghana, and Nigeria) with study sites conveniently selected in each country. Using the validated immunoassay kits, with already published validation procedures, SARS-CoV-2 antibodies were detected in peripheral blood during the ‘Delta’ and ‘Omicron’ waves. Participants' demographic and clinical data were obtained using a semi-structured questionnaire, and the primary outcome was the proportion of each population with SARS-CoV-2 antibodies.Findings: Across the 3 countries, 20,748 participants were recruited, and the results showed SARS-CoV-2 IgG seropositivity ranging between 24.1% to 77.0%, which increased during the Omicron wave. All sites showed low self-reported vaccination rates, delinking seropositivity and vaccination. While there was a significant positive association between seropositivity and age across all sites, the association with other demographic factors was country-dependent, and most participants expressed positive opinions of vaccination.Interpretation: This is one of the largest population-based SARS-CoV-2 seroepidemiology studies in Africa, confirming widespread mild SARS-CoV-2 infection in West Africa. This confirms a marked disconnect between high population exposure and low reported clinical burden, underscoring the need for strengthened community surveillance.

  • Innate lymphoid cells: unsung heroes or villains in multiple sclerosis pathogenesis?

    by Mansur Aliyu, Ali Akbar Saboor-Yaraghi, Mohamad Ali Sahraian, Farshid Noorbakhsh, Al-Mukhtar Yahuza Adamu, Alhassan Abdullahi Sharif, Zainab Aliyu Abdulqadir

    The emerging role of Innate Lymphoid Cells (ILCs) in the pathogenesis and regulation of Multiple Sclerosis (MS), a complex neuroinflammatory autoimmune disease, has been increasingly recognized. Once identified only for activities conducted at barrier surfaces, ILCs are now understood to be important modulators of inflammation and tissue repair within the Central Nervous System (CNS). This review aims to elucidate the ‘two sides of the coin’ nature of ILCs in MS. ILCs are implicated in pathogenesis by driving neuroinflammation through pro-inflammatory cytokines, contributing to the formation of ectopic meningeal lymphoid follicles, and modulating meningeal immune system interactions. In contrast, certain ILC subsets confer protective effects by secreting anti-inflammatory cytokines and promoting tissue homeostasis. Recent experimental and clinical studies have demonstrated the complex balance and alteration of ILC responsiveness at various stages of MS. We focused on the importance of ILC subset determination, including their dependence on key cytokine signaling pathways and their critical role in the gut-CNS axis, a pivotal mediator of systemic immunity in MS. Moreover, the potential for ILC pathway targeting, either by modulating cytokine networks or modifying the microbiota, is discussed as a promising avenue for restoring immune balance, promoting neuroprotection and suppressing ILC-driven inflammation. Despite the challenges presented by ILC plasticity and diversity, elucidating ILC biology offers a clear path toward developing precise immunomodulatory strategies aimed at halting disease progression and promoting CNS repair in patients with MS.


  • Open Access

    Detection and Species Distribution of Fungal Pathogens Associated with Otomycosis in a Tertiary Health Center in Kano, Nigeria

    by Khadija Muhammad Kawu, Muhammad Ibrahim Getso, Taysir Ramadan, Alhassan Abdullahi Sharif, Kanishka Hrishi Das, Al-Mukhtar Yahuza Adamu, Mansur Aliyu

    Otomycosis is the commonest cause of otitis externa seen in otorhinolaryngology clinics, especially in tropical and subtropical regions of the world. Diagnosis is usually made clinically and confirmed by laboratory identification of fungal elements. We conducted a cross-sectional and hospital-based epidemiological study that aimed to determine the prevalence, distribution and antifungal susceptibility profile of common aetiologic agents of otomycosis in Kano, northwestern Nigeria. We collected clinical samples from 300 patients who presented with symptoms of external ear infection, out of which 117 subjects (39.0%) were mycologically positive. Aspergillus species were the predominant isolate, with 90 (77.0%), followed by Candida species at 27 (23.0%). Otomycosis accounts for 39% of otitis externa seen in our center, mostly presenting with pruritus and otalgia. Raising the awareness of the general population to the predisposing factors may significantly reduce the incidence of otomycosis.

  • Open Access

    Intracellular Survival of Toxoplasma gondii: Success and Adaptation

    by Alhassan Abdullahi Sharif, Hassan Yahaya

    T. gondii was described as the most successful parasite on earth because of its wide range of host agents, intracellular adaptations and its ability to maintain continuous survival for the life span of its host. Its complex movement, penetration and intracellular replication within the host cell are organized in such a way that it invades and evades immune cells. Formation of parasitoporous vacoule within the host cells and strong anti-oxidant system, are factors that add to its ability to maintain itself in a latent stage, evasion of immune cells attack as well as the effects of reactive oxygen species. In immunocompetent individuals, the infection is asymptomatic, and the parasite exists and persists in a slowly replicating bradyzoite stage in skeletal muscle, heart, brain, retina, and placental tissues. Reactivation of the rapidly replicating tachyzoite stage in settings of immune-depression results with severe consequences. This, therefore, prompts the need to understand certain mechanisms through which this organism succeeds and adapts the harsh condition of host cells during infection. The review further portrays the applicability of diagnostics and therapeutics to diagnose, treat and prevent infection with T. gondii.

  • Open Access

    Investigation of Andrographolide Effect on Non-Infected Red Blood Cells Using the 1H-NMR-Based Metabolomics Approach

    by Ashraf Ahmad Issa Alapid, Roslaini Abd. Majid, Zaid O. Ibraheem, Ahmed Mediani, Intan Safinar Ismail, Ngah Zasmy Unyah, Sharif Alhassan Abdullahi, Norshariza Nordin, Mohammed Nasiru Wana, Rusliza Basir

    Andrographolide (AG) has been shown to have several medicinal and pharmaceutical effects, such as antimicrobial, anti-inflammatory, antioxidant, anti-diabetic, and anti-malarial activities. Moreover, studies to assess the pharmacological effect of AG on the metabolic changes of uninfected red blood cells (uRBCs) have not yet been investigated. This study aims to evaluate the pharmacological effects of AG compared to chloroquine (CQ) on the metabolic variations of uRBCs in vitro using a proton nuclear magnetic resonance (1H-NMR)-based metabolomics approach coupled with multivariate data analysis (MVDA). Forty-one metabolites were successfully identified by 1H-NMR. The results of the unsupervised data analysis principal component analysis (PCA) showed ideal differentiation between AG and CQ. PC1 and PC2 accounted for 71.4% and 17.7% of the explained variation, respectively, with a total variance of 89.10%. Based on S-plot and VIP values, a total of 28 and 32 metabolites were identified as biomarkers in uRBCs-AG and uRBCs-CQ, respectively. In uRBCs treated with AG, ten metabolic pathways were determined to be disturbed, including riboflavin metabolism, d-glutamate and d-glutamine metabolism, phenylalanine metabolism, glutathione metabolism, proline and arginine metabolism, arginine biosynthesis, citrate cycle, glycolysis/gluconeogenesis, and pyruvate metabolism as well as alanine, aspartate, and glutamate metabolism. In contrast, in CQ-treated uRBCs, nine affected metabolic pathways were determined, which involved the same metabolic pathways for uRBCs-AG, except for glutathione metabolism. These findings suggest an evident relationship between AG and CQ associated with metabolic changes in intact RBCs after being exposed to the treatment. The metabolomics results could allow useful comprehensive insights into the underlying mechanism of the action of AG and CQ on red blood cells. Consequently, the 1H-NMR-based metabolomics approach was successfully utilized to identify the pharmacological effects of AG and CQ on the metabolic variations of uRBCs.


  • Open Access

    Effects of Malaysian strains of Toxoplasma gondii on behaviours and their possible risk in schizophrenia-like rat model

    by Mohammed Nasiru Wana, Malaika Watanabe, Samaila Musa Chiroma, Ngah Zasmy Unyah, Sharif Alhassan Abdullahi, Onesimus Mahdi, Ashraf Ahmad Isa Alapid, Shariza Nordin, Rusliza Basir, Mohamad Aris Mohd Moklas, et al.

    Toxoplasma gondii ( T. gondii ) is a protozoan parasite that reside majorly in the brain of its intermediate host. T. gondii infected rodent’s shows some degree of behaviour deficits, while T. gondii infection in humans is associated with psychiatric problems such as schizophrenia. The present study aimed to evaluate the effects of Malaysian strains of T. gondii on rats. Forty five, four weeks old, male Wistar rats were used. The rats were assigned into five groups: two control groups (CG1 and CG2) and three experimental groups (EG1, EG2, EG3). CG1 rats received phosphate buffered saline (PBS), CG2 received MK-801 (as a model for schizophrenia), EG1, EG2, EG3 received orally 5 × 10 3 single T. gondii oocysts strain of type I, type II and type III respectively. After infection, all the five groups of rats were tested for T. gondii antibodies at two weeks post-infection (PI). Behavioural tests of exploratory activity (open field) and spatial learning and memory retention (Morris water maze) were performed on the ninth and tenth weeks PI followed by histological staining of rat brain. T. gondii IgM antibodies were detected in EG1, EG2 and EG3, but not in CG1 and CG2. The behaviour results demonstrated that rats from CG2, EG1, EG2 and EG3 had increased in their locomotor activities and memory deficits compared to control, while learning remain intact. Moreover, tissue cysts were found widely distributed exclusively in the whole brain of EG1, EG2 and EG3 without tropism. These findings taken together, implies that Malaysian strains of T. gondii are implicated in some causes of behaviour changes that are responsible for schizophrenia-like conditions if humans were infected.

  • Phytochemicals and Potential Therapeutic Targets on Toxoplasma gondii Parasite

    by Sharif Alhassan Abdullahi, Ngah Zasmy Unyah, Noshariza Nordin, Rusliza Basir, Wana Mohammed Nasir, Ashraf Ahmad Alapid, Yahaya Hassan, Tijjani Mustapha, Roslaini Abd Majid

    Identification of drug target in protozoan T. gondii is an important step in the development of chemotherapeutic agents. Likewise, exploring phytochemical compounds effective against the parasite can lead to the development of new drug agent that can be useful for prophylaxis and treatment of toxoplasmosis. In this review, we searched for the relevant literature on the herbs that were tested against T. gondii either in vitro or in vivo, as well as different phytochemicals and their potential activities on T. gondii. Potential activities of major phytochemicals, such as alkaloid, flavonoid, terpenoids and tannins on various target sites on T. gondii as well as other related parasites was discussed. It is believed that the phytochemicals from natural sources are potential drug candidates for the treatment of toxoplasmosis with little or no toxicity to humans.


  • Open Access

    Susceptibility of Toxoplasma gondii to Ethanolic Extract of Tinospora crispa in Vero Cells

    by Alhassan Abdullahi Sharif, Ngah Zasmy Unyah, Norshariza Nordin, Rusliza Basir, Mohammed Nasiru Wana, Ashraf Alapid Ahmad, Tijjani Mustapha, Roslaini Abd. Majid

    Background. Toxoplasmosis remains widely distributed globally and is one of the major neglected parasitic zoonotic infections. The infection is still endemic in most parts of the world due to poor control as well as challenges of the currently used medications which can be overcome by using natural products. This study evaluated the effect of ethanolic extract from the stem of Tinospora crispa (EETC) on host cell invasion and intracellular replication of Toxoplasma gondii. Method. The stem powder of T. crispa was soaked in absolute ethanol for 72 hours. The resulting ethanolic extract was screened for the presence of phytochemicals. Vero cells monolayer in 96-well plate was infected with RH strain of T. gondii and treated with concentrations of the EETC, Veratrine alkaloid, and clindamycin ranging from 1.56 to 200 μg/mL. MTT assay was conducted after 24 hours to evaluate the cytotoxicity and antiparasitic activities of the EETC. Four and 24 hours treatment models were adapted to assess the infection index and intracellular proliferation of T. gondii in vitro. Microscopic analysis was conducted after 24 and 48 hours exposure to EETC in both treatment models. Results. The study revealed that the EETC had no cytotoxic effects on Vero cells with IC50 = 179 μg/mL, as compared to clindamycin (IC50 = 116.5 μg/mL) and Veratrine alkaloid (IC50 = 60.4 μg/mL). The EETC had good anti-toxoplasma activities with IC50 = 6.31 μg/mL in comparison with clindamycin (IC50 = 8.33 μg/mL) and Veratrine alkaloid (IC50 = 14.25 μg/mL). The EETC caused more than 70% and 80% reduction in infection index and intracellular proliferation in both treatment models, respectively. Conclusion. This in vitro study showed that the EETC contains promising phytochemicals effective against T. gondii and safe to the host cells.